Amman Bradford K. 4
4 · Vivos Therapeutics, Inc. · Filed Dec 28, 2020
Insider Transaction Report
Form 4
Amman Bradford K.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2020-12-24$7.38/sh+1,000$7,380→ 1,000 total
Holdings
- 16,667
Stock Option
Exercise: $7.50Exp: 2024-11-18→ Common Stock (16,667 underlying) - 83,334
Stock Option
Exercise: $7.50Exp: 2023-10-22→ Common Stock (83,334 underlying)
Footnotes (2)
- [F1]83,334 stock options granted on October 22, 2018. One-fifth vested immediately and one-fifth vests annually on each anniversary date through October 22, 2022.
- [F2]16,667 stock options granted on November 18, 2019. One-fifth vested immediately and one-fifth vests annually on each anniversary date through November 18, 2023.